Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Dolan

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Blood|July 22, 2009
The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestryHemant Kulkarni, Vincent C Marconi, Weijing He, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black womenVeron Ramsuran, Hemant Kulkarni, Weijing He, et al.
Open Forum Infectious Diseases|May 2, 2022
Response to a Serogroup B Meningococcal Disease Case Among Military TraineesJoseph E Marcus, William N Bennett, Dianne N Frankel, et al.
JAMA Internal Medicine|November 25, 2014
Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individualsJason F Okulicz, Tuan D Le, Brian K Agan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levelsEnrique Gonzalez, Brad H Rovin, Luisa Sen, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
Nature Medicine|October 9, 2009
Reply to: "Experimental aspects of copy number variant assays at CCL3L1"Weijing He, Hemant Kulkarni, John Castiblanco, et al.
Science (New York, N.Y.)|January 8, 2005
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibilityEnrique Gonzalez, Hemant Kulkarni, Hector Bolivar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2004
Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trialScott A Wegner, Mark R Wallace, Naomi E Aronson, et al.
Nature Immunology|October 24, 2007
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanismsMatthew J Dolan, Hemant Kulkarni, Jose F Camargo, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Blood|July 22, 2009
The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestryHemant Kulkarni, Vincent C Marconi, Weijing He, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black womenVeron Ramsuran, Hemant Kulkarni, Weijing He, et al.
Open Forum Infectious Diseases|May 2, 2022
Response to a Serogroup B Meningococcal Disease Case Among Military TraineesJoseph E Marcus, William N Bennett, Dianne N Frankel, et al.
JAMA Internal Medicine|November 25, 2014
Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individualsJason F Okulicz, Tuan D Le, Brian K Agan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levelsEnrique Gonzalez, Brad H Rovin, Luisa Sen, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
Nature Medicine|October 9, 2009
Reply to: "Experimental aspects of copy number variant assays at CCL3L1"Weijing He, Hemant Kulkarni, John Castiblanco, et al.
Science (New York, N.Y.)|January 8, 2005
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibilityEnrique Gonzalez, Hemant Kulkarni, Hector Bolivar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2004
Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trialScott A Wegner, Mark R Wallace, Naomi E Aronson, et al.
Nature Immunology|October 24, 2007
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanismsMatthew J Dolan, Hemant Kulkarni, Jose F Camargo, et al.
Pageof 4